FindTrial
Sign In

Clinical characteristics and outcomes of cancer patients and their hospital course during the COVID-19 pandemic in a developing country

Clinical characteristics and outcomes of cancer patients and their hospital course during the COVID-19 infection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300067424
Enrollment
Unknown
Registered
2023-01-06
Start date
2020-03-08
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

non-cancer patients:COVID-19 positive
cancer patients:COVID-19 positive

Sponsors

none
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: There were 99 patients evaluated during their COVID-19 disease course. This included 28 cancer patients and 71 non-cancer patients. All were COVID-19 PCR positive patients who were admitted to out facility.

Exclusion criteria

Exclusion criteria: Those patients who were managed outpatient or were suspected cases of COVID-19 but their PCT returned negative were excluded from the study.

Design outcomes

Primary

MeasureTime frame
Disease course;—

Secondary

MeasureTime frame
Laboratory markers;—

Countries

Pakistan

Contacts

Public ContactMuhammad Sohaib Asghar

Dow University of Health Sciences

sohaib_asghar123@yahoo.com+923343013947

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026